Carregant...
Response of Degarelix treatment in human prostate cancer monitored by HR-MAS (1)H NMR spectroscopy
INTRODUCTION: The androgen receptor (AR) is the master regulator of prostate cancer cell metabolism. Degarelix is a novel gonadotrophin-releasing hormone blocker, used to decrease serum androgen levels in order to treat advanced human prostate cancer. Little is known of the rapid metabolic response...
Guardat en:
| Publicat a: | Metabolomics |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4927592/ https://ncbi.nlm.nih.gov/pubmed/27429605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-016-1055-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|